Related Experiment Video

Updated: May 14, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Familiarity, knowledge, and preferences of family physicians regarding mild cognitive impairment

Perla Werner1, Jeremia Heinik, Eliezer Kitai

  • 1Department of Gerontology University of Haifa, Haifa, Israel. werner@research.haifa.ac.il

International Psychogeriatrics
|January 26, 2013
PubMed
Abstract

Insights

Family physicians are familiar with mild cognitive impairment (MCI) but often lack detailed knowledge, with many incorrectly attributing it to normal aging. This highlights a need for improved physician education on MCI diagnosis and treatment.

Area of Science:

  • Geriatrics
  • Neurology
  • Primary Care Medicine

Background:

  • Mild cognitive impairment (MCI) is a prevalent condition in the elderly.
  • Early identification of MCI is crucial as it can precede dementia.
  • Physician knowledge and preferences significantly impact MCI identification.

Purpose of the Study:

  • To assess family physicians' familiarity with MCI.
  • To evaluate their knowledge regarding MCI diagnosis and treatment.
  • To understand their preferences for help-seeking and management of MCI.

Main Methods:

  • A structured questionnaire was administered to 197 family physicians in an Israeli HMO.
  • The study assessed physicians' familiarity, knowledge, and preferences concerning MCI.
  • Data were collected on help-seeking, diagnosis, and treatment options for MCI.

Main Results:

  • Most physicians had heard of MCI, but a third lacked substantial knowledge.
  • While knowledgeable about some causes, 70% incorrectly attributed MCI to normal aging.
  • Physicians' preferences for MCI help-seeking and treatment aligned with existing literature.

Conclusions:

  • There is a need to enhance primary care physicians' understanding of MCI.
  • Findings can inform the development of targeted educational programs for physicians.
  • Strengthening physician knowledge is essential for effective MCI management.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...